Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,849,649 papers from all fields of science
Search
Sign In
Create Free Account
E2F3 wt Allele
Known as:
RP1-177P22.2
, E2F Transcription Factor 3 wt Allele
, E2F-3
Expand
Human E2F3 wild-type allele is located in the vicinity of 6p22 and is approximately 147 kb in length. This allele, which encodes transcription factor…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
6p22
Cell Cycle
Cell Cycle Control
Homo sapiens
Expand
Narrower (1)
E2F3 Transcription Factor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells
S. Libertini
,
Honglin Chen
,
+4 authors
M. Mudryj
The Prostate
2012
Corpus ID: 35803123
The E2F/RB pathway is frequently disrupted in multiple human cancers. E2F3 levels are elevated in prostate tumors and E2F3…
Expand
2007
2007
Expression and clinical significance of E2F-1 and E2F-3 in bladder carcinoma
Y. Zhangqun
2007
Corpus ID: 76501794
Objective:To study the expression and clinical significance of E2F-1 and E2F-3 in bladder carcinoma.Methods:Immunohistochemistry…
Expand
2005
2005
Expression and clinical significance of E2F-3 and Bcl-2 in hepatocellular carcinoma
Xin-hua Ju
,
Ji-yang Zhang
,
Z. Xia
2005
Corpus ID: 71483148
Objective: To investigate the expression of E2F and Bcl-2 and the clinicopathological significance in hepatocellular carcinoma…
Expand
2004
2004
Mitoinhibitory effects of the tumor promoter 2-acetylaminofluorene in rat liver: loss of E2F-1 and E2F-3 expression and cdk 2 kinase activity in late G1.
L. Ohlson
,
Lena Koroxenidou
,
I. Porsch-Hällström
Journal of Hepatology
2004
Corpus ID: 46361686
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE